Industry

The confirmatory clinical, safety and efficacy study for AVT04, biosimilar candidate to Stelara® (ustekinumab) met its primary endpoint AVT04 (ustekinumab) is part of a broader pipeline of Alvotech’s biosimilars and biosimilar candidates, which includes AVT02 (adalimumab), a biosimilar to Humira® Alvotech is the second company to announce positive top-line results from a patient study utilizing … [Read more…]

TAMPA, Fla.–(BUSINESS WIRE)–Edgility, Inc. launches EdgeAi as healthcare’s first operationally embedded AI with Explainability. EdgeAi exposes the internal mechanics of machine learning and deep learning systems in human-understandable terms. Trust in AI model predictions is paramount if care providers and administrators are to accept the decisions based on them. EdgeAi generates a standard label for … [Read more…]

NEW YORK–(BUSINESS WIRE)–Enhanced Healthcare Partners (“EHP”), a leading private equity firm focused on investing in middle-market businesses in the healthcare sector, is pleased to announce its strategic investment in Howard J. Chudler & Associates (“HCA”), a behavioral therapy services provider for people with autism and intellectual and developmental disabilities. Founded in 1983, HCA is headquartered … [Read more…]

– EFFICACY: In the pivotal Phase 3 clinical trial program, VTAMA cream met all primary and secondary endpoints and demonstrated highly statistically significant improvement versus vehicle in Physician Global Assessment (PGA) score with 36% of patients versus 6% in vehicle in PSOARING 1 and 40% of patients versus 6% in vehicle in PSOARING 2 achieving … [Read more…]

First approval of a dry powder inhaler for treatment of PAH and PH-ILD DPI device represents a convenient option for administration of treprostinil therapy Commercial launch activities underway; patient availability expected in June 2022 SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the … [Read more…]

CAMBRIDGE, England–(BUSINESS WIRE)–CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), today announced the appointment of Dr Paul Brooks as Chief Business Officer. Key to the next stage of the Company’s growth, Paul will be responsible for shaping the company’s commercial business strategy and leading the expansion … [Read more…]

LONDON–(BUSINESS WIRE)–Digital disruptor in healthcare, Certific, expands its technology platform, enabling healthcare providers to undertake remote medical-testing, and scale the service to more patients. Starting with the launch of its Urinary Tract Infection (UTI) digital screening service, Certific’s process guides the patient through simple certified procedures, so that medical professionals can focus on more complex … [Read more…]

LONDON–(BUSINESS WIRE)–HIMSS (Healthcare Information and Management Systems Society) is bringing together healthcare and IT leaders who are navigating an extraordinary opportunity to advance the digital transformation of Europe’s health systems. Major changes prompted by the COVID-19 pandemic — including billions of euros invested in healthcare modernization, national regulatory initiatives and the proposed EU legislation for … [Read more…]

Data presentations include review of the VE303 Phase 2 CONSORTIUM study, in which VE303 was well tolerated and highly active at preventing Clostridioides difficile infection recurrence in subjects at high risk of recurrence Further CONSORTIUM study analysis shows that the VE303 high dose led to more robust colonization, which in turn correlated with prevention of … [Read more…]

Data presentations include review of the VE303 Phase 2 CONSORTIUM study, in which VE303 was well tolerated and highly active at preventing Clostridioides difficile infection recurrence in subjects at high risk of recurrence Further CONSORTIUM study analysis shows that the VE303 high dose led to more robust colonization, which in turn correlated with prevention of … [Read more…]